What is PointCross?
PointCross, Inc. operates as a sophisticated provider of enterprise software solutions tailored for industries where knowledge discovery and metadata management are critical to operational success. The company maintains a dual-focus business model, serving the Exploration and Production (E&P) sector with comprehensive asset management suites like SAMS and IEPS, while simultaneously delivering robust biopharma R&D solutions. Its biopharma portfolio, which includes the drug safety information management suite (DSIMS) and ToxVision, is essential for organizations navigating the complexities of nonclinical study data and regulatory reporting. By integrating advanced search capabilities with customizable workflows, PointCross enables firms in finance, defense, and life sciences to streamline their decision-making processes and ensure compliance with stringent industry standards.
How much funding has PointCross raised?
PointCross has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PointCross
PPP
Public-Private Partnership
What's next for PointCross?
With this recent strategic investment, PointCross is poised to scale its managed services and expand its footprint in the global market. The company's roadmap likely involves enhancing its cloud-based delivery models, such as its SaaS-based regulatory review tools, to meet the increasing demand for remote, data-driven collaboration. By focusing on the intersection of technical search and regulatory compliance, PointCross is set to capitalize on the growing need for automated, stage-gated processes in the biopharma and energy sectors. The firm's ability to maintain a global presence across California, Texas, France, and India provides a solid foundation for continued innovation and service delivery in the coming fiscal periods.
See full PointCross company page